Market revenue in 2023 | USD 16.7 million |
Market revenue in 2030 | USD 33.1 million |
Growth rate | 10.2% (CAGR from 2023 to 2030) |
Largest segment | Medical |
Fastest growing segment | Dental |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Medical, Biosensors, Consumer/Personal Product Testing, Bioinks, Food and Animal Product |
Key market players worldwide | EnvisionTEC, Organovo Holdings Inc, 3D Systems Corp, Inventia Life, Poietis, Vivax Bio, Cyfuse Biomedical, Cellink, Regemat 3D |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d bioprinting market will help companies and investors design strategic landscapes.
Medical was the largest segment with a revenue share of 38.32% in 2023. Horizon Databook has segmented the Sweden 3d bioprinting market based on dental, medical, biosensors, consumer/personal product testing, bioinks, food and animal product covering the revenue growth of each sub-segment from 2018 to 2030.
The rising need for 3D bioprinting technology is driven by its potential to address critical healthcare challenges. Sweden actively engages in research, innovation, and developing a supportive ecosystem to harness this technology’s potential. The presence of a major player, Cellink, contributes to the country’s market share.
Cellink, headquartered in Gothenburg, has become one of the world’s top 3D bioprinting companies, firmly placing Sweden at the forefront of this potentially ground-breaking new technology. With its 3D printers and biomaterials for synthetic biology and regenerative medicine, Cellink is a leader in the bioprinting industry across Sweden.
Furthermore, in May 2023, the third generation of CELLINK’s LUMEN XTM device was launched, likely to become the industry standard for benchtop DLP bioprinting. The market growth in the future is likely to be boosted by these kinds of strategic efforts.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden 3d bioprinting market , including forecasts for subscribers. This country databook contains high-level insights into Sweden 3d bioprinting market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account